Rise and shine. Another day is on the way. Hello, everyone, hope all is well as you gear up for those meetings and deadlines. We can relate. To cope, we are brewing the mandatory cup of stimulation. Feel free to indulge yourself, or grab a water bottle if you prefer. Meanwhile, here are a few items to help you get started. Have a good one and stay in touch...
Pay For Delays Deals Nearing A Turning Point? (Bloomberg News)
FDA To Decide On Orexigen Obesity Pill In January (Reuters)
Merck To Cut 800 Jobs In France (La Tribune)
Merck KGgA Resumes Vaccine Trial For Lung Cancer (Reuters)
UK's NICE Refuses To Cover Roche's Tarceva (PharmaTimes)
Medicare To Review Coverage Of Anemia Drugs (Reuters)
AstraZeneca May Fight Canadian Court Ruling On Nexium Generic (Bloomberg)
Industry Groups Adopt Joint Postion On Trial Publication (OutsourcingPharma)